If you or someone is experiencing an opioid overdose — call 911 immediately. If naloxone (Narcan) is available, administer it right away. For crisis support: SAMHSA Helpline: 1-800-662-4357 (free, 24/7, confidential).
What is Opioid Use Disorder (OUD)?
Opioid use disorder (OUD) is a chronic brain disease characterized by compulsive opioid use despite harmful consequences. It is classified as a substance use disorder in the DSM-5 and is recognized by every major medical organization — including the National Institutes of Health, the American Medical Association, and the World Health Organization — as a legitimate medical condition, not a character flaw.
Opioids include both prescription medications (oxycodone, hydrocodone, codeine, morphine, fentanyl) and illegal drugs (heroin). They work by binding to opioid receptors in the brain, reducing pain and producing euphoria. With repeated use, the brain adapts — requiring higher doses to achieve the same effect (tolerance) and producing physical distress when the drug is stopped (withdrawal).
According to the CDC, over 80,000 Americans died from opioid overdoses in 2021 — making OUD one of the most urgent public health crises in US history.
DSM-5 Diagnostic Criteria for OUD
A diagnosis of opioid use disorder requires at least 2 of the following 11 criteria within a 12-month period:
- Taking opioids in larger amounts or for longer than intended
- Persistent desire or unsuccessful efforts to cut down
- Spending excessive time obtaining, using, or recovering from opioids
- Strong cravings or urge to use opioids
- Repeated failure to fulfill major work, school, or home obligations
- Continued use despite persistent social or interpersonal problems
- Giving up or reducing important activities due to opioid use
- Using opioids in physically hazardous situations
- Continued use despite knowing it causes physical or psychological harm
- Tolerance — needing more to get the same effect
- Withdrawal — characteristic opioid withdrawal syndrome when stopping
Severity: 2–3 criteria = mild OUD | 4–5 = moderate | 6+ = severe OUD
Warning Signs of Opioid Addiction
Recognizing OUD early significantly improves treatment outcomes. Key behavioral, physical, and psychological warning signs include:
- Doctor shopping (multiple prescribers)
- Stealing medication or money
- Sudden social withdrawal
- Neglecting responsibilities
- Secretive behavior
- Pinpoint pupils
- Drowsiness / "nodding off"
- Slowed breathing
- Weight loss
- Track marks (if injecting)
Risk Factors for Opioid Use Disorder
Anyone prescribed opioids can develop OUD, but certain factors increase risk:
- Personal or family history of substance use disorder
- Mental health conditions — depression, anxiety, PTSD, trauma history
- High-dose or long-term opioid prescriptions (30+ days)
- Young age — the brain is more susceptible to addiction before age 25
- Social environment — peer pressure, access to drugs, unstable housing
- Chronic pain — long-term opioid therapy for pain management
FDA-Approved Treatment Options for OUD
OUD is a treatable medical condition. The most effective approach combines medication-assisted treatment (MAT) with behavioral therapy. Multiple FDA-approved options exist:
1. Buprenorphine (Suboxone, Subutex)
Buprenorphine is a partial opioid agonist that reduces cravings and withdrawal without producing a strong euphoric effect. Suboxone (buprenorphine + naloxone) is the most commonly prescribed MAT medication in the US. It can be prescribed by certified physicians in an office setting — making it highly accessible. Studies show it reduces opioid use by 50–70% and significantly decreases overdose deaths.
2. Methadone
Methadone is a full opioid agonist dispensed daily at licensed opioid treatment programs (OTPs). It eliminates withdrawal symptoms and cravings when dosed correctly. Methadone has been used for OUD treatment for over 50 years and has the strongest evidence base of any MAT medication. It requires daily clinic visits initially but is highly effective for severe OUD.
3. Naltrexone (Vivitrol)
Naltrexone is an opioid antagonist — it blocks opioid receptors so opioids produce no effect. Available as a daily pill or monthly injection (Vivitrol). It requires complete opioid detoxification before starting (7–10 days opioid-free). Best suited for motivated patients in early recovery who have completed detox.
4. Behavioral Therapies
Used alongside medication: Cognitive Behavioral Therapy (CBT) addresses thought patterns and behaviors that drive use. Contingency management rewards opioid-free urine tests. 12-step programs (Narcotics Anonymous) provide peer support. Therapy is most effective when combined with MAT.
How to Get Help for Opioid Use Disorder
Crisis & Treatment Resources
- SAMHSA National Helpline: 1-800-662-4357 — free, confidential, 24/7, treatment referrals
- Crisis Text Line: Text HOME to 741741
- Find Treatment: findtreatment.gov
- 988 Suicide & Crisis Lifeline: Call or text 988
- Narcotics Anonymous: na.org
Related reading: Naloxone (Narcan): How It Reverses Opioid Overdose | Hydrocodone Complete Guide | Oxycodone Complete Guide
Frequently Asked Questions About Opioid Use Disorder
What is opioid use disorder?
Opioid use disorder is a chronic medical condition involving compulsive use of opioids — including prescription painkillers and illegal drugs like heroin — despite negative consequences. It is recognized as a brain disease caused by neurological changes from repeated opioid exposure, not a moral or character failure.
Can you recover from opioid use disorder?
Yes — millions of Americans are in long-term recovery from OUD. With medication-assisted treatment (buprenorphine, methadone, or naltrexone) combined with behavioral support, most people can achieve and maintain recovery. OUD is a chronic condition requiring ongoing management, but full, productive lives are absolutely possible.
Is MAT (medication-assisted treatment) just replacing one drug with another?
No — this is a common misconception. MAT medications like buprenorphine and methadone, when used as prescribed under medical supervision, stabilize brain chemistry, block cravings, and allow people to function normally. The WHO, CDC, NIDA, and SAMHSA all endorse MAT as the gold standard treatment for OUD. Refusing MAT to people with OUD would be like refusing insulin to diabetics.